Griffin Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.37M | Sell |
|
|||||
|
2024
Q1 | $1.52M | Sell |
|
|||||
|
2023
Q4 | $1.68M | Buy |
|
|||||
|
2023
Q3 | $1.51M | Hold |
|
|||||
|
2023
Q2 | $1.48M | Buy |
|
|||||
|
2023
Q1 | $1.44M | Sell |
|
|||||
|
2022
Q4 | $1.55M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $358K | Sell |
|
|||||
|
2021
Q4 | $1.06M | Buy |
|
|||||
|
2021
Q3 | $883K | Sell |
|
|||||
|
2021
Q2 | $994K | Sell |
|
|||||
|
2021
Q1 | $1.03M | Buy |
|
|||||
|
2020
Q4 | $990K | Buy |
|
|||||
|
2020
Q3 | $843K | Buy |
|
|||||
|
2020
Q2 | $1.33M | Sell |
|
|||||
|
2020
Q1 | $916K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $20K | Buy |
|